PHARMACY CONSULTING LIMITEDActive
Key figures
Like most small UK companies, PHARMACY CONSULTING LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2025/26Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £41,155 (6% of the profit for the year).
Filed accounts2020/21–2025/26
| 2020/21 | 2021/22 | 2023/24 | 2024/25 | 2025/26 | |
|---|---|---|---|---|---|
| Profit for the year | — | 655,138 | — | — | — |
| Cash at bank and in hand | — | 1,157,843 | 626,854 | 761,581 | 791,777 |
| Total assets | 923,124 | 1,343,663 | 1,548,842 | 1,777,982 | 1,727,472 |
| Total liabilities | 342,898 | 148,747 | — | — | — |
| Net assets / total equity | 580,933 | 1,194,916 | 1,408,881 | 1,574,886 | 1,607,767 |
| Average number of employees | 9 | 9 | 10 | 11 | 10 |
| Dividends paid | — | 41,155 | — | — | — |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: PHARMACY CONSULTING LIMITED
Company
PHARMACY CONSULTING LIMITED is a private limited company registered with Companies House under company number 04469518. It was incorporated on 25 Jun 2002. Its status is active. The registered office is in Farnborough (GU14). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).
Accounts
The latest accounts in the database are for 2025/26 (period ending 31 Mar 2026); the company files small company accounts (filleted). Net assets were £1,607,767, up 2.1% on the previous year. Cash at bank and in hand was £791,777. The company had an average of 10 employees. Figures are available for 5 financial years (2020/21–2025/26).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 10 Dec 2026.